Exploring Methylene Blue and Its Derivatives in Alzheimer's Treatment: A Comprehensive Review of Randomized Control Trials

Methylene blue (MB) and its compounds are investigated for their potential benefits in the management of Alzheimer's disease (AD). AD is a widely seen neuropathological disorder characterized by the gradual decline of cognitive abilities, ultimately leading to the development of severe dementia...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashmi, Muhammad Usman, Ahmed, Ragda, Mahmoud, Sulafa, Ahmed, Kholood, Bushra, Noura M, Ahmed, Areeg, Elwadie, Batran, Madni, Amna, Saad, Amel B, Abdelrahman, Nadir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631450/
https://www.ncbi.nlm.nih.gov/pubmed/38022191
http://dx.doi.org/10.7759/cureus.46732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631450/
https://www.ncbi.nlm.nih.gov/pubmed/38022191
http://dx.doi.org/10.7759/cureus.46732

Ejemplares similares